Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Burbulla, Lena F., Song, Pingping, Mazzulli, Joseph R., Zampese, Enrico, Wong, Yvette C., Jeon, Sohee, Santos, David P., Blanz, Judith +8 more·2017·Science
DOI 10.1126/science.aam9080

Cited by (875)

Items 701–800 of 875

  1. Structural damage of myelin in experimental Parkinsonism and prospects for their drug correction in the clinic of Parkinson's disease
    K. V. Rozova, Tatiana Gasyuk, N.V. Karasevich, Karaban' In · 2022 · Ageing & Longevity
  2. Cogs in the autophagic machine—equipped to combat dementia-prone neurodegenerative diseases
    Sholto de Wet, Rensu P. Theart, Ben Loos · 2023 · Frontiers in Molecular Neuroscience
  3. The Ca2+-Regulated Enzymes Calpain and Calcineurin in Neurodegenerative Processes and Prospects for Neuroprotective Pharmacotherapy
    Varduhi H. Knaryan, F. P. Sarukhanyan · 2024 · Neuroscience and Behavioral Physiology
  4. Translational View on Therapeutic Strategies and Upcoming Issues: Stem Cell and Brain Organoid Approaches for Parkinson’s Disease Therapy
    Francesco Gubinelli, Jose M. Salazar, Janina Kaspar, Irene Santisteban Ortiz, Simon T. Schafer, Lena F. Burbulla · 2024 · Neuromethods
  5. The role of parkin in monkey
    Pingping Song, Dimitri Krainc · 2024 · Protein & Cell
  6. Breaking through the blood-brain barrier for different kinds of drugs: challenges, solutions, and perspectives
    Peiyi She, Xiang Ao, Xue Zhan, Wenxuan Zhou, Yu Cheng, H. J. Yang, Siyu Wu, Xiaolin Zhang, Wanghui Peng, Juan Wang · 2024 · BME Horizon
  7. Distinct astrocyte activation patterns associated with neuroinflammation induced by gamma and proton beam irradiation
    Liben Yan, Tianyi Er, Shaoqian Sun, Yulin Deng, Zhirong Wan, Jing Zhao, Ailu Wang, BH Liu, Qiaojuan Wang, Sui Li et al. · 2025 · Scientific Reports
  8. Neuronal design and determinants of selective neuronal vulnerability of dopaminergic neurons in Parkinson's disease
    Enrico Zampese, James Moran, D. James Surmeier · 2025 · Handbook of behavioral neuroscience
  9. Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration
    Leonie M. Heger, Leonie Kertess, Clara Kaufhold, Francesco Gubinelli, Aida Cardona‐Alberich, Gamze Özata, Stephan A. Müller, Sarah K. Tschirner, Oliver Stehling, Martina Schifferer et al. · 2025 · Movement Disorders
  10. Exploring self-nanoemulsifying drug delivery system (SNEDDS) in combating neurodegeneration: a revolutionary tool for drug targeting in Alzheimer’s and Parkinson’s disease
    Shivani Tyagi, Jayendra Kumar, Shobhit Kumar · 2025 · Journal of Dispersion Science and Technology
  11. Single‐Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Ferroptosis‐Related Genes in Parkinson's Disease
    Meijun Liu, Min Yang, Keyun Guo, Si-Jia Zhu, Jie Yang · 2025 · European Journal of Neuroscience
  12. The Enigma of Neuromelanin: How Animal Models Can Help Researchers to Understand the Link Between Pigments and Neurodegeneration
    Svenja Esser, Maximilian Hausherr, Katrin Marcus · 2025 · Biomedicines
  13. Pyridoxamine inhibits dopamine-induced α-synuclein oligomerization through scavenging neurotoxic dopamine quinone
    Seon Hwa Lee, Naoya Matsumoto, Akane Terada, Yusuke Hatakawa, Tomoyuki Oe · 2025 · Scientific Reports
  14. Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson’s disease
    Jessica Jiaxin Xie, Matas Vitkauskas, Quyen Do, Tzuen Yih Saw, Alfred Xuyang Sun, Lin Yang, Tuck Wah Soong, Lim Kah‐Leong, Eng‐King Tan, Huck‐Hui Ng et al. · 2026 · iScience
  15. Selective neurodegeneration in patients with parkinson’s disease
    Furkat A. Yusupov, M.Sh. Abdykadyrov · 2026 · S S Korsakov Journal of Neurology and Psychiatry
  16. The role of mitochondria-associated membranes in tumorigenesis
    Yaqin Zhu, Guoyi Tang, Muya Tang, Baozhen Zhou, Jing Xu, Xiaoli Ma, Ziyu Li, Guichun Liu, Yu Han · 2026 · Discover Oncology
  17. Reimagining the contribution of iron in Parkinson's disease
    Rebecka O. Serpa, Emily Tufano, James R. Connor · 2026 · Neurobiology of Disease
  18. Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis
    Muntajin Rahman, Khadija Akter, Amama Rani, Moon Nyeo Park, Bonglee Kim · 2026 · Nutrients
  19. Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona-Alberich, Naiyareen F. Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2026 · Scientific Reports
  20. A druggable link between the angiotensin receptor 1 and α-synuclein pathology revealed in scalable human cellular models of Parkinson’s disease
    Mathieu Daynac, Vincent Mouilleau, Annabel Menendez, Yuxi Liu, Xiaoyu Yang, Yin Shen, Su Guo · 2026 · Molecular Neurodegeneration Advances
  21. Subacute Exposure to Macrocyclic Lactone Insecticides Induces Parkinson’s Disease-like Motor Deficits and Neuropathology in Mice
    Jinjing Xiao, Yuying Liu, Shujie Wang, Kaijie Dai, Zhuang Ye, Su Shi, Zengxue Liu, Haiqun Cao, Yanhong Shi · 2026 · Environmental Science & Technology
  22. Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson’s disease
    Yifan Li, Qiang Li, Yemin Wang, Xuejing Wang, Guangfu Di, Meng Niu, Zhiliang Xu, Yanjiao Huang · 2026 · Journal of Physiology and Biochemistry
  23. Lysosomal dysfunction in neurodegenerative disease
    Sarah M. Brooker, Robert Coukos, Dimitri Krainc · 2026 · Nature Reviews Neurology
  24. Aging with Parkinson’s Disease
    Joe R. Nocera, Keith McGregor · 2018 · Handbooks in health, work, and disability
  25. ) Musa acuminata Colla Millsp ameliorates paraquat-induced memory deficit and oxidative stress in murine Parkinson disease model
    Adebimpe O. Ogunnoiki, Ismail Ogunbayode Ishola, Moshood Olusola Akinleye, Olufunmilayo Olaide Adeyemi · 2022 · Nigerian Journal of Pharmacy
  26. Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy
    Varduhi H. Knaryan, F. P. Sarukhanyan · 2023 · S S Korsakov Journal of Neurology and Psychiatry
  27. ProSE-Pero: Peroxisomal Protein Localization Identification Model Based on Self-Supervised Multi-Task Language Pre-Training Model
    Jianan Sui, Jiazi Chen, Yuehui Chen, Naoki Iwamori, Jin Sun · 2023 · Frontiers in Bioscience-Landmark
  28. Meta-analysis of the association of prosaposin polymorphisms rs4747203 and rs885828 with risk of Parkinson’s disease
    Liuhui Zhu, Xinyue Zhang, Ying Guan, Yongyun Zhu, Qian Zhou, Bin Liu, Hui Jun Ren, Xinglong Yang · 2024 · Acta Neurologica Belgica
  29. Protocol to investigate Parkinson’s patient-derived dopaminergic neurons by live-cell microscopy and oxidized dopamine assays
    Pingping Song, Dimitri Krainc · 2024 · STAR Protocols
  30. Analysis of dopaminergic neuron-specific mitochondrial morphology and function using tyrosine hydroxylase reporter iPSC lines
    Mutsumi Yokota · 2024 · Anatomical Science International
  31. Dopamine oxidation mediates a time‐dependent pathological cascade in Parkinson's disease
    Leonora Kulikovskaja, Philip Seibler · 2017 · Movement Disorders
  32. Extra-virgin Olive Oil, the Mediterranean Diet, and Neurodegenerative Diseases
    Antonio Capurso, Gaetano Crepaldi, Cristiano A. Capurso · 2018 · Practical issues in geriatrics
  33. MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE LESIONS IN RAT BRAIN UNDER MODELING OF PARKINSON’S LIKE SYNDROME: CORRECTIVE ACTION OF CAPICOR
    Man'kovs'ka Im, Olga O. Gonchar, VI Nosar, K. V. Rozova, Larisa. V. Bratus, Evgenia E. Kolesnikova, Yu. V. Putiy, Karaban' In · 2018 · Fìzìologìčnij žurnal
  34. Monoamine Oxidase Inhibitor (MAO-I)-Mediated Neuroprotection for Treating Parkinson’s Disease
    Toshiharu Nagatsu, Akira Nakashima · 2019 · Springer eBooks
  35. Progress in generating iPSC-derived dopaminergic neurons as accurate models of neurodegenerative disease
    Richard Sam, Tae‐Un Han, Ellen Sidransky, Yu Chen · 2021 · Elsevier eBooks
  36. Features of the mitochondrial dysfunction development in Parkinson’s disease, possibilities of drug correction for ultrastructural disorders
    E. V. Rozova, Olga O. Gonchar, Karaban' In, Nina Karasevych, Maryna Khodakovska, N.O. Melnik · 2024 · INTERNATIONAL NEUROLOGICAL JOURNAL
  37. Dopamine and Serotonin Metabolism in Parkinsonian Models
    Carmen De La Fuente Barrigon · 2018 · UCL Discovery (University College London)
  38. Novel computational deep learning strategy for neuroprotection identification reveals unique set of nicotine analogs as potential therapeutic compounds against Parkinson’s disease
    Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Mauricio Pinzón, George Emilio Barreto, Ricardo Cabezas, Leonardo Mariño‐Ramírez, Janneth González · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear Palsy
    Imogen Tyer, Alison Hill · 2020 · Preprints.org
  40. The zinc ionophore clioquinol reduces Parkinson’s disease patient-derived brain extracts-induced neurodegeneration
    Margaux Teil, Évelyne Doudnikoff, Marie-Laure Thiolat, Sylvain Bohic, Erwan Bézard, Benjamin Dehay · 2022 · Research Square
  41. Mitochondrial fitness influences neuronal excitability of dopaminergic neurons from patients with idiopathic form of Parkinson’s disease
    Paula Chlebanowska, Agata Szlaga, Anna Tejchman, Marta Kot, Paweł S. Konieczny, Klaudia Skrzypek, Agata Muszyńska, Małgorzata Katarzyna Sobocińska, Krystyna Golebiowska, Paweł P. Łabaj et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  42. GBA1 mutations alter neuronal firing and structure, regulating VGLUT2 and CRYAB in dopamine neurons
    Eva Rodríguez‐Traver, Luz M. Suárez, Carlos Crespo, Irene González-Burgos, Rebeca Vecino, Juan Camilo Jurado-Coronel, María Galán, Marta González-González, Rosario Moratalla, Carlos Vicario‐Abejón · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration
    Sofia Zaichick, Ekaterina A. Grebenik, Gabriela Caraveo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Scalable Human Cellular Models of Parkinson’s Disease Reveal A Druggable Link Between the Angiotensin Receptor 1 and α-Synuclein Pathology
    Mathieu Daynac, Vincent Mouilleau, Yuxi Liu, Xiaoyu Yang, Yin Shen, Su Guo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Parkinsonism Reversal and Dopaminergic Resilience: Lessons from a Rotenone-induced Parkinson’s Disease Model
    Prince Joshi, Fan Fan, Xuelin Lou · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Papers of note in Science 357 (6357)
    Annalisa M. VanHook · 2017 · Science Signaling
  47. High priority publications on Parkinson's disease in 2017
    Tanya Simuni, Dimitri Krainc · 2017 · The Lancet Neurology
  48. Natural and Synthetic GHSR1a Agonists as Neuroprotective Agents in Models of Parkinson's disease
    Daniel J. Rees · 2017
  49. Lysosomal and mitochondrial crosstalk: the role of lysosomal signaling on mitochondrial biogenesis and function
    King Faisal Yambire · 2018
  50. Pallidopyramidal Syndrome and Hereditary Spastic Paraplegia common features and diagnostic approach and therapeutic considerations
    Corneliu Angelo Bulboacă, Mihai Blidaru, Dana Gabriela Festila, Paul-Mihai Boarescu, Ioana Stănescu · 2019 · Balneo Research Journal
  51. Investigating early functional alteration in a human iPSC-based model of Parkinson’s Disease
    Giulia Carola · 2019 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  52. Investigation into the effect of LRRK2-Rab10 protein interactions on the Proboscis Extension Response of the fruit fly Drosophila melanogaster
    Laura Covill · 2018 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  53. Development of analytical tools to enrich and identify protein dopaminylation
    Emily Jane Myers · 2020 · ResearchWorks at the University of Washington (University of Washington)
  54. Modernized Divination into Ferroptosis
    Rahul R Jain · 2020 · International Journal for Research in Applied Science and Engineering Technology
  55. Chemical biology: a toolbox to unlock neurochemical epigenetics?
    Dennis Özcelik · 2020 · Neural Regeneration Research
  56. Parkinson's disease: Genetic-driven therapeutic approaches
    S. Pablo Sardi, Marco A. S. Baptista · 2020 · Elsevier eBooks
  57. Pharmacocorrection of mitochondrial dysfunction and energy imbalance of substantia nigra neurons in experimental Parkinson's disease in rats
    Volodymyr Maramukha · 2020 · Journal of Education Health and Sport
  58. IS THERE AN ORGAN-SPECIFIC EXPRESSION OF CANDIDATE GENES (DJ1, PINK1) IN TISSUES OF THE ORGANISM UNDER EXPERIMENTAL PARKINSONISM AND ITS PATHOGENETIC THERAPY?
    Rozova Kateryna Vsevolodovna, Yu. V. Putiy · 2021 · Science Review
  59. The role of oxidative stress and the underlying biological pathways in the pathogenesis of Parkinson’s Disease
    Bela Peethambaran, Chelsea Leonce, Amrut Patel · 2021 · International Journal of Complementary & Alternative Medicine
  60. Characterisation of the ghrelinergic system in human models of neurodegenerative diseases
    Maria Carla Carisi · 2021
  61. Targeting Catecholamines to Develop New Drugs for Attention Deficit Hyperactivity Disorder
    Sung‐Cherl Jung, Chang-Hwan Cho, Hye‐Ji Kim, Eun‐A Ko, Min-Woo Ha, Oh-Bin Kwon · 2021 · Journal of Medicine and Life Science
  62. Mitochondrial dysfunction and energy changes of black-substance neurons in experimental parkinson's disease in rats and mothors
    N. M. Buchakchyiska, Igor F. Belenichev, Volodymyr Maramukha · 2021 · Modern medical technology
  63. Spatiotemporally Mapping Thermodynamics of Lysosomes and Mitochondria using Cascade Organelle-Targeting Upconversion Nanoparticles
    Xiangjun Di, Qian Peter Su, Dejiang Wang, Yongtao Liu, Mahnaz Maddahfar, Jiajia Zhou, Dayong Jin · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Faculty Opinions recommendation of Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
    Siegfried Hekimi, Alycia Noë · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. References
    2018 · Elsevier eBooks
  66. Tetramethylpyrazine nitrone exerts neuroprotection via PGC-1α/Nrf2 activation and α-synuclein clearance in Parkinson’s disease models
    Baojian Guo, Chengyou Zheng, Jie Cao, Shangming Li, Fangcheng Luo, Xiaoling Qiu, Kun Zhang, Wei Cai, Haitao Li, Ying Wang et al. · 2020
  67. The zinc ionophore clioquinol reduces Parkinson’s disease patient-derived brain extracts-induced neurodegeneration
    Margaux Teil, Évelyne Doudnikoff, Marie-Laure Thiolat, Sylvain Bohic, Erwan Bézard, Benjamin Dehay · 2022 · Research Square
  68. Patient-derived cells – an irreplaceable tool for research of reduced penetrance in movement disorders
    Philip Seibler, Aleksandar Raković · 2022 · Medizinische Genetik
  69. Pathogenesis
    Roger L. Albin · 2022 · Oxford University Press eBooks
  70. Ankylosing Spondylitis Complicated with Parkinson’s Disease: A Case Report and Literature Review
    雪梅 周 · 2023 · Advances in Clinical Medicine
  71. Development of Mesenchymal Stem Cells Therapy for the Treatment of Polyglutamine SCA: From Bench to Bedside
    Chih‐Yuan Ho, Hsiu-Yu Lai, Ling-Mei Wang, Bing‐Wen Soong · 2023 · Contemporary clinical neuroscience
  72. Mitochondrial Dysfunction and Parkinson’s Disease
    洋 刘 · 2023 · Advances in Clinical Medicine
  73. Sterol Biomarker Discovery In Neurodegenerative Diseases
    Manuela Pacciarini · 2023
  74. Venglustat in GBA1-related Parkinson's disease – Authors' reply
    S. Pablo Sardi, Nir Giladi, Roy N. Alcalay, Gary Cuer, Thomas Gasser, Tanya Gurevich, Günter U. Höglinger, KENNETH L. MAREK, Claudio PaccheE, Anthony H.V. Schapira et al. · 2024 · The Lancet Neurology
  75. Safety, Tolerability, and Pharmacokinetics of the Monoamine Oxidase B Inhibitor, HEC122505, and its Major Metabolite After Single- and Multiple- Ascending Dose, and Food Effect Study in Healthy Chinese Subjects
    Chuanfei Jin, Chao Yi, Kangzhi Chen, Haiping Liang · 2024 · European Journal of Drug Metabolism and Pharmacokinetics
  76. Characterization of the molecular interaction between α-synuclein and prion protein
    Renato Domingues · 2024
  77. A Gut Feeling: Biomedical Knowledge Graphs for Interrelating the Gut Microbiome and Mental Health
    Ting Liu · 2024
  78. PIKfyve Inhibition Controls Inflammatory Gene Expression Networks and Activates TFEB via Oxidative Stress
    Michael Mercer · 2024
  79. PIKfyve Inhibition Controls Inflammatory Gene Expression Networks and Activates TFEB via Oxidative Stress
    Michael Mercer · 2024
  80. Identification of diagnose related therapeutic targets of Danggui buxue decoction in Parkinson’s disease
    Man Jin, Kaisheng Ye, Defeng Hu, Jiefang Chen, Sha Wu, Shumei Chi · 2024 · Brain Research
  81. Pivotal roles of mitochondria in linking dopamine catabolism to axonal myelination: Implication for the pathogenesis and treatment of schizophrenia
    Haiyun Xu, Fan Yang, Yi Zhang, Cuiting Jiang, Na Ouyang, Qianqian Wang, Ping Wang, Peiwen Zheng, Wei Wang, Handi Zhang et al. · 2024 · Research Square
  82. Mitochondrial dysfunction induced by trichloroethylene in Parkinson’s disease
    Neda M. Ilieva, Ashley B. Adamson, Mohammed Ghalib, Teel Walters, Briana R. De Miranda · 2024 · Advances in neurotoxicology
  83. CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
    Platon Megagiannis, Guy Armand Rouleau, Yang Zhou · 2024 · Elsevier eBooks
  84. References
    2024 · Elsevier eBooks
  85. Inflammatory Roads to Parkinson’s Disease
    Hymie Anisman, Shawn P. Hayley, Alexander Kusnecov · 2024 · Elsevier eBooks
  86. Genetic association between mitochondrial DNA copy number and glioma risk: insights from causality
    Qiang He, Wenjing Wang, Dingkang Xu, Yang Xiong, Chuanyuan Tao, Lu Ma, Junpeng Ma, Songping Zheng, Chao You, Xin Zan · 2024 · BMC Cancer
  87. Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders
    Zhangzhong Yang, Peng Lei · 2024 · Scientia Sinica Vitae
  88. The OMICS and PD models: Hopes or hypes
    Kholoud Elsamman · 2024 · Elsevier eBooks
  89. Mitochondrial-Derived Vesicles Mediate Interorganellar Communication via Selective Cargo Transfer Under Oxidative Stress
    Ashutosh Sharma · 2025 · Preprints.org
  90. Human induced pluripotent stem cell-derived astrocyte and neuron co-culture model for neuroinflammation modeling
    Boning Qiu, Massimiliano Caiazzo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Alanine tRNA Fragment Regulation of Long Non-Coding RNA MEG3 Accompanies Parkinson's Disease Non-Motor Symptoms
    Tamara Zorbaz, Estelle R. Bennett, Shani Vaknine, Nimrod Madrer, Arbel Zeira, David Greenberg, Iddo Paldor, Hermona Soreq · 2025 · SSRN Electronic Journal
  92. Anti-Parkinson Effect of Methanolic Extract of Ribes fasciculatum in C. elegans
    Zi Won Park, Wooin Yang, Hoon Bae Jeon · 2025 · 생약학회지
  93. Nanotechnology-enhanced neuroprotection: a novel idebenone nanoprodrug conjugate strategy for Parkinson's disease
    Xinhao Yan, Meixin Mao, Shiting Feng, Fei Lan, Tianjin Li, Hongyuan Li, Yin Yao, Juanjuan Gao, Minyan Li, Peng Sen Wu · 2025 · Bioorganic Chemistry
  94. Understanding human dopamine neuron biology in Parkinson's patient cells
    Gizem Onal, Maria Claudia Caiazza, Parnaz Sharifi, Iona Thomas-Wright, Johanna L. Hoffmann, Rachel Heon‐Roberts, Richard Wade-Martins · 2025 · Handbook of behavioral neuroscience
  95. Multiomic profiling reveals aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona‐Alberich, Naiyareen Fareeza Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. BASP1 Couples Ca 2+ Signaling and Actin Polymerization to Mitochondrial Fission Essential for Neurite Outgrowth
    Ekaterina A. Grebenik, Sofia Zaichick, Angel Gomez, Gabriela Caraveo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Natural Compounds and Mitochondrial Function
    Mohsin Vahid Khan, Mohd. Rumman, Gulam Rabbani, Mohd Kamil Hussain, Sameer Ahmad, Nafees Ahmad · 2025 · Springer eBooks
  98. Alpha-synuclein fibrils induce budding of mitochondrial-derived vesicles
    Thomas Braun, Viviane Reber, Cinzia Tiberi, Andri Fränkl, Dhiman Ghosh, Roland Riek, Tetiana Serdiuk · 2026 · Proceedings of the National Academy of Sciences
  99. Aging-driven organelle miscommunication in the failing heart
    Angélica Ortega, Elsa Bascuñan-Ortiz, Mayarling Francisca Troncoso, Claudia Muñoz-Rodríguez, Laura Navarrete-Gallegos, Rut Yero-Haber, Brenda Becerra, Aracely Mora, Erik Lopez‐Gallardo, Mario Chiong et al. · 2025 · The Journal of Cardiovascular Aging
  100. Loss of the Parkinson’s disease-associated protein DJ-1 impacts dopamine metabolism in astrocytes
    Annika Wagener, Naiyareen Fareeza Mayeen, Stephan A. Müller, Sarah K. Tschirner, Brigitte Nuscher, Pauline Mencke, Stefan F. Lichtenthaler, Ibrahim Boussaad, Rejko Krüger, Lena F. Burbulla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)